As the global burden of obesity, type 2 diabetes, and metabolic syndrome continues to rise, fatty liver disease has become one of the most prevalent chronic liver conditions worldwide. Its progressive ...

As the global burden of obesity, type 2 diabetes, and metabolic syndrome continues to rise, fatty liver disease has become one of the most prevalent ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), ...

A research team in Xinjiang Uygur Autonomous Region in northwest China has developed a novel diagnostic technique that ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received CE Mark approval for its Elecsys® Apolipoprotein E4 ...

Researchers at Brown University have demonstrated that targeted electrical stimulation of the spinal cord can restore both ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an ...

Background Endovascular therapy (EVT) is standard treatment for large vessel occlusion in patients with a National Institutes ...

A team of researchers in Germany has frozen adult mouse brain tissue at cryogenic temperatures and, after thawing it, recorded electrical activity that closely resembled normal function. The work, ...

CLDN18.2-high expression occurred in 48.3% of evaluable advanced cases, exceeding historical estimates and supporting routine standardized immunohistochemistry aligned with zolbetuximab phase III ...

(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured an advancement in metastatic castration resistant prostate cancer (mCRPC) therapy session and a presentation by Dr ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...